Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71522 |
FLM-5011
|
||
FLM-5011 is a a lipoxygenase inhibitor with anti-inflammatory effects. | |||
T71520 |
LEQ-506
|
||
LEQ506, also known as NPV-LEQ506, is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity. Smoothened antagonist LEQ506 selectively binds to the Hedgehog (Hh)-ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway, thereby inhibiting tumor cell growth. |